Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
Leukemia Research|August 27, 2015
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.Hematological Oncology|January 30, 2024
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohortEnrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, et al.The Journal of Antimicrobial Chemotherapy|November 15, 2024
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world studyMario Tumbarello, Gabriele Giuliano, Marianna Criscuolo, et al.Hematological Oncology|August 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All StudyPatrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, et al.Leukemia|December 17, 2024
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirementJana Nabki, Bashar Al Deeban, Abel Mehari Sium, et al.Cancers|September 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All StudyNicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.Mycoses|October 25, 2021
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B surveyMaria Ilaria Del Principe, Giulia Dragonetti, Allegra Conti, et al.Cancer|March 22, 2025
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemiaCristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi, et al.British Journal of Haematology|November 6, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL studyMichelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, et al.Pageof 15